Jeong, J.; Seo, S.; Kim, S.-B.; Song, J.S.; Kim, H.R.; Cho, B.C.; Jung, M.; Kim, C.G.; Hong, M.; Hong, M.H.;
et al. Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum. Cancers 2025, 17, 3149.
https://doi.org/10.3390/cancers17193149
AMA Style
Jeong J, Seo S, Kim S-B, Song JS, Kim HR, Cho BC, Jung M, Kim CG, Hong M, Hong MH,
et al. Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum. Cancers. 2025; 17(19):3149.
https://doi.org/10.3390/cancers17193149
Chicago/Turabian Style
Jeong, Jiyun, Seyoung Seo, Sung-Bae Kim, Joon Seon Song, Hye Ryun Kim, Byoung Chul Cho, Minkyu Jung, Chang Gon Kim, Moonki Hong, Min Hee Hong,
and et al. 2025. "Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum" Cancers 17, no. 19: 3149.
https://doi.org/10.3390/cancers17193149
APA Style
Jeong, J., Seo, S., Kim, S.-B., Song, J. S., Kim, H. R., Cho, B. C., Jung, M., Kim, C. G., Hong, M., Hong, M. H., & Park, S. R.
(2025). Real-World Outcomes and Biomarker Analysis Based on Routine Clinical, Laboratory, and Pathologic Parameters in Metastatic or Unresectable Esophageal Cancer Treated with First-Line Anti-PD-1 Plus Fluoropyrimidine and Platinum. Cancers, 17(19), 3149.
https://doi.org/10.3390/cancers17193149
